Want to see TSE:VHI full AI Analyst Report?
VHI Stock Chart & Stats
C$7.91
-C$0.14(-1.23%)
At close: 4:00 PM EST
C$7.91
-C$0.14(-1.23%)
Day’s Range― - ―
52-Week RangeC$6.62 - C$14.64
Previous CloseN/A
Volume94.87K
Average Volume (3M)148.97K
Market Cap
C$468.12M
Enterprise ValueC$413.04M
Total Cash (Recent Filing)C$121.27M
Total Debt (Recent Filing)C$2.60M
Price to Earnings (P/E)61.0
Beta0.85
Next Earnings
Aug 07, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.13
Shares Outstanding63,259,563
10 Day Avg. Volume164,389
30 Day Avg. Volume148,972
Financial Highlights & Ratios
PEG Ratio1.48
Price to Book (P/B)2.08
Price to Sales (P/S)5.09
P/FCF Ratio70.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$12.80Price Target Upside61.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.28
Revenue Forecast (FY)C$130.78M
Bulls Say, Bears Say
Bulls Say
High Gross & EBITDA MarginsSustained ~75% gross margin and ~20% EBITDA margin reflect strong unit economics from software products and services. High gross margins provide pricing power and room to invest in R&D and sales while maintaining durable operating leverage across contract renewals and multi-year deployments.
Very Conservative Balance SheetExtremely low leverage reduces financial risk and preserves flexibility to fund organic growth, platform investments, or tuck-in acquisitions without reliance on costly debt. This financial conservatism supports resilience through industry cycles and regulatory uncertainty in healthcare tech.
Recurring Revenue Business ModelA subscription and maintenance-led revenue mix creates predictable, repeatable cash flows and higher customer lifetime value. Combined with services-driven onboarding, this model supports retention, cross-sell, and durable revenue visibility across hospital and health-system contracts.
Bears Say
Weak Near-term Cash ConversionVery low operating cash flow-to-net-income implies cash timing or working-capital pressure despite accounting profits. Persistent weak cash conversion can constrain reinvestment, slow integration of acquisitions, and force reliance on equity or external financing for growth initiatives.
Modest Net Margin And ROEModerate net margin and low ROE indicate the company generates limited return on its equity base. Over time this can signal dilution from acquisitions or insufficient operating leverage to translate high gross margins into strong shareholder returns, pressuring capital efficiency.
Gross-margin Trend WeakeningA declining gross margin trend may reflect pricing pressure, a shift toward lower-margin services, or integration/implementation costs from M&A. If this persists it erodes the core profitability cushion and requires higher revenue growth to sustain absolute profits.
Vitalhub News
VHI FAQ
What was Vitalhub’s price range in the past 12 months?
Vitalhub lowest stock price was C$6.62 and its highest was C$14.64 in the past 12 months.
What is Vitalhub’s market cap?
Vitalhub’s market cap is C$468.12M.
When is Vitalhub’s upcoming earnings report date?
Vitalhub’s upcoming earnings report date is Aug 07, 2026 which is in 33 days.
How were Vitalhub’s earnings last quarter?
Vitalhub released its earnings results on May 07, 2026. The company reported C$0.04 earnings per share for the quarter, missing the consensus estimate of C$0.06 by -C$0.02.
Is Vitalhub overvalued?
According to Wall Street analysts Vitalhub’s price is currently Undervalued.
Does Vitalhub pay dividends?
Vitalhub does not currently pay dividends.
What is Vitalhub’s EPS estimate?
Vitalhub’s EPS estimate is 0.07.
How many shares outstanding does Vitalhub have?
Vitalhub has 63,259,563 shares outstanding.
What happened to Vitalhub’s price movement after its last earnings report?
Vitalhub reported an EPS of C$0.04 in its last earnings report, missing expectations of C$0.06. Following the earnings report the stock price went up 0.756%.
Which hedge fund is a major shareholder of Vitalhub?
Currently, no hedge funds are holding shares in TSE:VHI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitalhub Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$12.80 (61.82% Upside)
C$12.80 (61.82% Upside)
Blogger Sentiment
Bullish
TSE:VHI Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth C$3.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.6%
Last 30 Days ▲ 0.9%
Last 30 Days ▲ 0.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.33%
12-Months-Change
Fundamentals
Return on Equity
2.98%
Trailing 12-Months
Asset Growth
51.17%
Trailing 12-Months
Company Description
Vitalhub
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
VHI Stock 12 Month Forecast
Average Price Target
C$12.80
▲(61.82% Upside)
Technical Analysis
Diagnos
―
kneat.com
―
nDatalyze Corp
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―
Options Prices
Currently, No data available
---